000

DAIHANPHARM

No trades
See on Supercharts
Market capitalization
‪168.60 B‬KRW
‪28.43 B‬KRW
‪195.91 B‬KRW
‪3.40 M‬
Beta (1Y)
0.27

About DAIHANPHARM

CEO
Yoon-Woo Lee
Website
Headquarters
Seoul
Employees (FY)
708
Founded
1945
ISIN
KR7023910003
FIGI
BBG000C1MB31
Daihan Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical products. The company operates through Pharmaceutical products and Other. Its main products include sap ample and contract research services. The company was founded by In-Sil Lee in 1945 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 023910 is 28050 KRW — it has decreased by 0.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAIHANPHARM stocks are traded under the ticker 023910.
023910 stock is 1.44% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is DAIHANPHARM there?
DAIHANPHARM revenue for the last quarter amounts to ‪48.70 B‬ KRW despite the estimated figure of ‪49.70 B‬ KRW. In the next quarter revenue is expected to reach ‪51.50 B‬ KRW.
Yes, you can track DAIHANPHARM financials in yearly and quarterly reports right on TradingView.
023910 stock has risen by 0.36% compared to the previous week, the last month showed zero change in price, over the last year DAIHANPHARM has showed a 1.23% decrease.
023910 net income for the last quarter is ‪5.89 B‬ KRW, while the quarter before that showed ‪7.86 B‬ KRW of net income which accounts for −24.98% change. Track more DAIHANPHARM financial stats to get the full picture.
Today DAIHANPHARM has the market capitalization of ‪164.93 B‬, it has decreased by 1.06% over the last week.
Yes, 023910 dividends are paid annually. The last dividend per share was 750.00 KRW. As of today, Dividend Yield (TTM)% is 2.67%. Tracking DAIHANPHARM dividends might help you take more informed decisions.
DAIHANPHARM dividend yield was 2.70% in 2023, and payout ratio reached 15.51%. The year before the numbers were 2.12% and 15.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 023910 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAIHANPHARM stock right from TradingView charts — choose your broker and connect to your account.
023910 reached its all-time high on Jan 15, 2018 with the price of 52700 KRW, and its all-time low was 1050 KRW and was reached on Oct 28, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 708.00 employees. See our rating of the largest employees — is DAIHANPHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAIHANPHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAIHANPHARM stock shows the neutral signal. See more of DAIHANPHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAIHANPHARM EBITDA is ‪44.45 B‬ KRW, and current EBITDA margin is 22.69%. See more stats in DAIHANPHARM financial statements.